Pipeline Watch: Three Approvals And Two Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Scrip - August 10, 2026

GI Endoscopy Carries Olympus As FDA Ship-Holds And China Test Its Recovery
Olympus's Q1 FY2027 beat — revenue up 16%, adjusted operating margin up 640bps to 12.8% — was driven almost entirely by GI endoscopy and a leaner cost base, but an unresolved FDA warning letter, US import alert and a 17% China decline kept management from touching full-year guidance.
Medtech Insight - August 10, 2026

Regulatory Recap: Biosimilar Legislations Progress In US Congress
Generics Bulletin reviews global regulatory developments across the world.
Generics Bulletin - August 10, 2026

Indian Panel Urges Full US Tariff Exemption For Generics
An Indian parliamentary committee wants generics fully protected from future US tariff hikes under a bilateral trade deal, while also urging faster mutual recognition agreements, pre-clearance mechanisms and policy support for exposed exporters.
Generics Bulletin - August 10, 2026

Generics Price-Fixing Case Heads To Jury Trial In February 2027
A Connecticut federal judge has fixed a February 2027 jury trial for the sprawling generics antitrust case, while Perrigo has won dismissal of several product claims but remains exposed on a much broader set of alleged conspiracies.
Generics Bulletin - August 10, 2026

Deals Shaping The Industry, July 2026
An interactive look at pharma, medtech and diagnostics deals made during July 2026. Data courtesy of Biomedtracker.
In Vivo - August 10, 2026

Eli Lilly Looks To Block US Rivals To Mounjaro
Eli Lilly has sued 14 generic challengers seeking to rival Mounjaro and Zepbound, opening a broad US patent battle over tirzepatide that spans compound, composition and method-of-treatment claims running as late as 2041.
Generics Bulletin - August 10, 2026

Senate Includes One-Month Delay On Lower THC Limits For Hemp In Continuing Resolution
Senate adds language to continuing resolution to delay imposing lower limit on all forms of THC allowed in lawful hemp rather than 0.3% concentration for delta-9 THC alone used to define de-scheduled hemp in 2018 farm bill.
HBW Insight - August 10, 2026

Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: Novo Nordisk weighs bolt-on deals; Bayer slams Germany pricing; Lilly soars despite Foundayo struggles; European biotech wants to leapfrog; and a look at the potential AstraZeneca/BMS combination in APAC.
Scrip - August 10, 2026